BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Bio-Techne Corp. (TECH) PT Lowered to $500 at Stifel
August 4, 2022 3:52 PM EDTStifel analyst Daniel Arias lowered the price target on Bio-Techne Corp. (NASDAQ: TECH) to $500.00 (from $560.00) while maintaining a Buy rating following results.
The analyst commented, "TECH's finish to fiscal 2022 was solid, and marked by 14% organic that brought FY22 to 16%. Looking to FY23, mgmt's... More
Bio-Techne (TECH) Misses Q4 EPS by 3c
August 4, 2022 6:42 AM EDTBio-Techne (NASDAQ: TECH) reported Q4 EPS of $2.05, $0.03 worse than the analyst estimate of $2.08. Revenue for the quarter came in at $288.2 million versus the consensus estimate of $287.12 million.
For earnings history and earnings-related data on Bio-Techne (TECH) click here.
... More